Chronos Archive seal

Review checklist: Bruce Lee (HR-ML044)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the seizure-versus-syncope reasoning, classing the seizure as unprovoked despite cannabis use, heat and sleep loss the same day, the decision not to start an antiseizure medicine, the driving advice under Hong Kong rules, the stunt-work restrictions, the fluid advice, and the choice of pain medicines for his back.
provenance reviewnot_startedSources: Bruce Lee Enterprises, two South China Morning Post articles (one citing the Post's 1973 reports), the Clinical Kidney Journal article (2022), an Epilepsy & Behavior letter (title only), HISTORY.com, Phoenix Television, a Hong Kong government press release and the Bruce Lee Foundation. The New York Times archive and the 1973 inquest record were not read. The 1973 cause of death is recorded as disputed.
safe messaging reviewnot_startedCannabis use is recorded from the cited accounts without judgment and marked sensitive; no substance use disorder is diagnosed. His wife and daughter are not named, and no living person is given a statement, decision or health fact. Unproven theories about his death (assassination and the like) are not recorded.

Judgment calls (dossier editorial resolutions)

  1. Sources. The case relies on Bruce Lee Enterprises (his family's company), two South China Morning Post articles (one citing the Post's own reports from July and September 1973), the peer-reviewed Clinical Kidney Journal article, HISTORY.com, Phoenix Television, a Hong Kong government press release and the Bruce Lee Foundation. The New York Times archive, the 1973 inquest record and the Post's 1973 articles themselves were not read; no biography page was found on the Bruce Lee Foundation's site, so its About page is used only for his legacy. Britannica, Wikipedia and aggregator sites were not used. The Epilepsy & Behavior letter was read as a title only.
  2. Recent-death rule. He died in 1973, so the rule does not apply; only documented claims are used, and a sick visit is included.
  3. Living people. His wife and daughter are living or may be, and are not named anywhere in the record, including source locators; nothing is attributed to them. Others present on July 20, 1973, and the clinicians who treated him in 1973 are not named in claim statements; the London pathologist (deceased) is named only in a quoted source locator, and his parents only in the Chinese-name locator. His father appears in a claim and in the family history. No real person is given a modern statement, decision or health fact; the colleague who describes the seizure and his health care agent are synthetic and unnamed.
  4. Name. The display name is Bruce Lee. “Lee” alone is not an alias, because it appears in other records. The aliases are Lee Jun-fan (the romanization in the Clinical Kidney Journal; Bruce Lee Enterprises writes “Jun Fan” as a given name) and 李振藩 (Phoenix Television); neither appears in any other record. The stage name 李小龍 (Lee Siu-lung; “Lee Siu Loong” in Bruce Lee Enterprises) is recorded in a claim but not used as an alias. identity.name_parts is not used: the name splits simply into given name Bruce and family name Lee.
  5. Cause of death. The cause of the cerebral oedema that killed him is recorded as disputed. The inquest verdict (misadventure) and the hospital's finding (acute cerebral oedema) are D (CLM-0012, CLM-0013). The explanation favored at the inquest, hypersensitivity to Equagesic (CLM-0014), and the later proposals of hyponatraemia (CLM-0015), heat stroke (CLM-0016), epilepsy (CLM-0017) and cannabis (CLM-0018) are R with certainty “disputed”; none is adopted. Theories of assassination and the like are not recorded. Claims about anabolic steroids, diuretics and cocaine that the Clinical Kidney Journal article attributes to one biographer were not used: they rest on a single secondary account and are not needed for the episode.
  6. The May 10, 1973 collapse. That he collapsed twice while dubbing, vomited, was in critical condition and was treated for cerebral oedema with mannitol is D (CLM-0007). That he convulsed rests on his biographer's account, quoted in the Clinical Kidney Journal (CLM-0008, D “probable”), as does the unventilated room (CLM-0009). The Clinical Kidney Journal names Hong Kong Baptist Hospital; the Post articles do not name the hospital in the text read.
  7. Index age and dates. The index visit on May 14, 2026 maps to May 14, 1973, four days after the collapse, when he was 32 and in Hong Kong. The synthetic date of birth is 1993-11-27, keeping the true month and day, a shift of 53 years. The other visits (May 18, June 15, 22 and 29, and July 13, 2026) map to the same days of 1973, all before his death on July 20. No visit falls between May 19 and June 14, 1973, because he was examined in the United States on May 25 and on May 29 and 30 (CLM-0011); the date he returned to Hong Kong is not documented in the sources read, and nothing read places him away from Hong Kong after mid-June.
  8. Setting. The project facility (St. Posthumous Health Center) is modeled as a clinic in Kowloon with an affiliated epilepsy clinic, and the driving advice uses Hong Kong rules. The preventive visit and the guideline frameworks are the U.S. ones used throughout the dataset; this is a modeling choice.
  9. Divergence from 1973. The modern episode does not reproduce the 1973 care. The modern CT and MRI show no brain swelling, whereas cerebral oedema was diagnosed in 1973; the modern clinicians start no antiseizure medicine, whereas phenytoin was prescribed in 1973; the modern sodium values are normal, and the record does not test or endorse the hyponatraemia hypothesis. The modern fluid advice (drink to thirst, with salt in the heat) is general teaching, not a claim about his death.
  10. Presenting problem and diagnosis. The presenting problem is a convulsive collapse, seizure versus convulsive syncope (R55, verification provisional), resolved at the epilepsy clinic into a first unprovoked seizure (R56.9, recorded at the epilepsy clinic, placement both_with_link to the documented collapse). R56.9 is used because a single seizure is not epilepsy; no G40 code is used.
  11. Unprovoked, not acute symptomatic. Judgment call: cannabis the same morning, a week of short sleep, missed meals and heat are treated as triggers, not acute symptomatic causes, because sodium, glucose and calcium were normal, he was not intoxicated by his account, and cannabis is not an established epileptogenic drug (Beghi 2010). A reviewer could reasonably class the seizure as provoked; the treatment decision would be the same.
  12. No antiseizure medicine. Judgment call under the AAN/AES 2015 guideline: with a normal MRI and EEG, a daytime seizure and no prior brain insult, he chose no immediate medicine after the risks and benefits were explained, with levetiracetam or lamotrigine planned after a second unprovoked seizure.
  13. Driving. Hong Kong's driving licence regulations list epilepsy and liability to sudden fainting among the conditions for which a licence must be refused or cancelled; the Transport Department form read gives no seizure-free interval, and the regulations themselves were not read. The clinic advises at least six months without driving, citing the UK DVLA rule for a first unprovoked seizure as an example of common practice. This is a judgment call.
  14. Cannabis. His cannabis use on the day of the May 10 collapse and the cannabis found at autopsy are recorded from the cited accounts (sensitive content), without judgment. The modern episode records occasional use, counsels without judgment and diagnoses no cannabis use disorder (no F12 code), so no safety assessment is required; he chooses to stop for now.
  15. Back pain and medicine choices. The chronic low back pain (M54.50) is anchored to the documented 1970 injury (CLM-0005); its description of an injury to the fourth sacral nerve is as Bruce Lee Enterprises reports it. Acetaminophen as needed, exercise therapy and, at the sick visit, a seven-day course of naproxen were chosen because they neither lower the seizure threshold nor interact with antiseizure medicines; tramadol, bupropion, cyclobenzaprine, carisoprodol and meprobamate were avoided. The NSAID advice includes not forcing water, because NSAIDs impair water excretion.
  16. Synthetic clinical picture. Everything in the modern episode is synthetic: the symptoms, the witness account, the emergency department values (narrative), every laboratory value, the ECG, MRI and EEG findings, the pain scores, PHQ-2 and AUDIT-C, the screening results (HIV, hepatitis B and C, narrative), medicines and outcomes. Height (171 cm) and weights (57.6 to 59.4 kg) are synthetic; his biographer's report that he weighed 54 kg before his death is not used as a measurement. Reference ranges are typical adult male ranges.
  17. Sick visit. A flare of low back pain with muscle spasm after a training kick, chosen because it follows from his documented back injury and tests medicine choices after a seizure, without insinuating an undocumented diagnosis. The saddle sensation and bladder and bowel questions are asked because of the reported sacral nerve injury.
  18. Preventive visit. A periodic adult preventive visit at 32 (CPT 99395 and 99497 in plain text). Judgment calls: HIV, hepatitis C and hepatitis B screening (the last because he was raised in Hong Kong, where hepatitis B is more common), Tdap and the first dose of HepB-CpG that day, HPV vaccine declined by shared decision at 32, and influenza and COVID-19 vaccines deferred to the autumn. A health care agent from his household is recorded without a name.
  19. CMID. The CMID has no monograph for seizures or low back pain, so it is not cited; the focused visits use the AAN/AES, ILAE and ACP guidance instead.
  20. Focused visits. The three chronic-care follow-ups (the epilepsy clinic four days after intake, one month and two months) are documented as focused visits on the AAN/AES 2007 evaluation and 2015 management guidance, the ILAE 2017 classification and 2014 definition, and the ACP 2017 low back pain guideline. One deviation is recorded instead of an invented result: the creatine kinase and creatinine repeat due about a week after the first visit was missed because he was away for work and no visit was booked; at five weeks both were normal (168 U/L and 0.96 mg/dL), so no harm resulted, and the corrective action is booked laboratory visits with a reminder. Repeat MRI and EEG are recorded as not indicated, with reasons. Synthetic findings introduced: the normal MRI and EEG, the falling creatine kinase and the back flare.
  21. Consultation. The epilepsy referral and the consultation by Priyanka Abernathy-Leung, MD (a fictional consultant), at the epilepsy clinic four days after intake, are S. The consultant answers the five referral questions in line with what the record shows afterwards: an epileptic seizure rather than syncope, classed as unknown-onset motor (tonic-clonic); a normal MRI and EEG; a first unprovoked seizure that is not epilepsy; no antiseizure medicine, which he chose, with one to start after a second seizure; and no driving for six months, no heights or swimming alone, no cannabis, fluids to thirst with electrolytes, and avoidance of tramadol, bupropion, carisoprodol and meprobamate. The six-month review is a plan only.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-06-15
Progress note 03 (C-CDA)
Creatine kinase and creatinine after a convulsive seizure with exertionUntil normal (about one week, then as needed)The repeat due about a week after the epilepsy clinic was missed: he was away for work and no laboratory visit was booked for it. Today, five weeks after the seizure, creatine kinase is 168 U/L and creatinine 0.96 mg/dL (eGFR 108), both normal, so no harm resulted. Corrective action: repeat tests are now booked as laboratory visits with a reminder the day before, rather than left to the next clinic visit

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-06-29
Progress note 05 (C-CDA)
PreventionHIV screeningOrderedOne-time screening for adults 15 to 65; never tested; blood drawn today
2026-06-29
Progress note 05 (C-CDA)
PreventionHepatitis C screeningOrderedOne-time screening for adults 18 to 79; blood drawn today
2026-06-29
Progress note 05 (C-CDA)
PreventionHepatitis B screeningOrderedOnce in adulthood with the triple panel (surface antigen, surface antibody and core antibody); he was raised in Hong Kong, where hepatitis B is common; blood drawn today

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0014The explanation favored at the inquest: a hypersensitivity reaction to the aspirin or meprobamate in Equagesic, or both, caused the cerebral oedema, as proposed by a London professor of forensic medicine and supported by the hospital pathologist who performed the postmortem. Critics note that neither drug is known to cause cerebral oedema and that he had taken the drug before.disputed
CLM-0015In 2022 nephrologists in Madrid proposed, from publicly available information, that the cerebral oedema was caused by hyponatraemia: that his kidneys could not excrete excess water, with risk factors that may have included high chronic fluid intake, cannabis, prescription drugs, alcohol, low solute intake, a past acute kidney injury and exercise.disputed
CLM-0016His biographer proposed heat stroke: the dubbing room on May 10 was unventilated, he had lost weight from overwork, and he had had the sweat glands removed from his armpits months before. The Madrid authors judged axillary sweat gland removal insufficient to impair heat loss.disputed
CLM-0017Others have proposed epilepsy, including sudden unexpected death in epilepsy; there is no record that he had epilepsy, and the neurologist who evaluated him after May 10 did not diagnose it.disputed
CLM-0018Some Hong Kong doctors believed cannabis brought on the cerebral oedema; no causal link between cannabis and cerebral oedema has been documented, and this explanation has been dismissed as speculation.disputed

Sensitive claims

ClaimGradeStatement
CLM-0010DHe had used cannabis (hashish) on the day of the May 10 collapse; the Hong Kong neurosurgeon who treated him thought it was a factor, an explanation he rejected.
CLM-0013DA nine-day coroner's inquest with testimony from pathologists from several countries followed; doctors at the inquest disagreed about what had caused the cerebral oedema, the medical evidence was insufficient to prove that the drug caused it, and a verdict of death by misadventure was recorded. Traces of cannabis were found in his stomach and intestine.
CLM-0015RIn 2022 nephrologists in Madrid proposed, from publicly available information, that the cerebral oedema was caused by hyponatraemia: that his kidneys could not excrete excess water, with risk factors that may have included high chronic fluid intake, cannabis, prescription drugs, alcohol, low solute intake, a past acute kidney injury and exercise.
CLM-0018RSome Hong Kong doctors believed cannabis brought on the cerebral oedema; no causal link between cannabis and cerebral oedema has been documented, and this explanation has been dismissed as speculation.

Diagnoses not confirmed

ProblemCodeVerificationReason
Sudden collapse with loss of consciousness four days before the visit, after hours of voice recording in a hot booth with the air conditioning off: felt hot and faint, lost consciousness, generalized stiffening then jerking of all four limbs for about a minute, vomiting, and 20 to 30 minutes of confusion; seizure versus convulsive syncope; emergency evaluation the same dayR55provisionalSynthetic presenting problem anchored to the documented collapse at the dubbing studio; resolved into a first seizure at the epilepsy clinic when the history, examination, ECG, MRI and EEG were reviewed together. Not a claim about his real symptoms beyond the cited accounts.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-05-14Creatine kinase820 U/L (high)High